|Articles|January 15, 2002
CDC focuses on medical response to bioterrorism threat
Baltimore-The Centers for Disease Control and Prevention (CDC) has been at the forefront of the medical response to the bioterrorism threat in recent months since the first case of inhalation anthrax was identified.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Rayner’s RayOne EMV Toric intraocular lens
2
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
3
NeuroOp Guru: When proptosis isn’t thyroid eye disease
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5